# Stribild

NDC: 61958-1201
Generic name: elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate
Labeler / Manufacturer: Gilead Sciences, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20120827

FDA application: NDA203100

## Active ingredients

- COBICISTAT: 150 mg/1
- ELVITEGRAVIR: 150 mg/1
- EMTRICITABINE: 200 mg/1
- TENOFOVIR DISOPROXIL FUMARATE: 300 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"61958-1201"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=61958-1201
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=74ae2a93-b267-444c-8f0f-a2a6522260ee